Literature DB >> 15383207

FDG PET and PET/CT imaging in lymphoma and melanoma.

Homer A Macapinlac1.   

Abstract

FDG PET imaging is rapidly gaining acceptance in numerous clinical applications in oncology. PET/CT is a new imaging tool, which takes advantage of the excellent anatomic resolution of CT and the biologic characterization provided by FDG PET which together results in improvement in accuracy of detecting the extent of disease, provide a guide to biopsy or surgery, allow early response evaluation and prognostication. This article will provide specific clinical applications for the utilization of these imaging modalities in both lymphoma and melanoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383207     DOI: 10.1097/00130404-200407000-00007

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  5 in total

1.  PET-positive fibrous dysplasia--a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery.

Authors:  Klaus Strobel; Beata Bode; Didier Lardinois; Ulrich Exner
Journal:  Skeletal Radiol       Date:  2006-05-20       Impact factor: 2.199

2.  Clinical Applications of PET and PET-CT.

Authors:  S S Anand; H Singh; A K Dash
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.

Authors:  Georgia M Beasley; Colin Parsons; Gloria Broadwater; M Angelica Selim; Suroosh Marzban; Amy P Abernethy; April K S Salama; Edward A Eikman; Terence Wong; Jonathan S Zager; Douglas S Tyler
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

4.  Anatomical and molecular imaging of skin cancer.

Authors:  Hao Hong; Jiangtao Sun; Weibo Cai
Journal:  Clin Cosmet Investig Dermatol       Date:  2008-10-07

5.  GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives.

Authors:  Gerardo Cazzato; Anna Colagrande; Antonietta Cimmino; Caterina Abbatepaolo; Emilio Bellitti; Paolo Romita; Lucia Lospalluti; Caterina Foti; Francesca Arezzo; Vera Loizzi; Teresa Lettini; Sara Sablone; Leonardo Resta; Gennaro Cormio; Giuseppe Ingravallo; Roberta Rossi
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.